AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Analyst Ranking
Bottom 13%
#4492 out of 5143 analysts
Average Return
-2.82%
Win Rate
47%8 out of 17
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alnylam Pharmaceuticals IncALNY
+71.42%$235.95$404.46
2025-01-06 -
2025-12-10
Buy
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-01 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-27 -
2024-07-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-20 -
2024-03-20
Buy
Regeneron Pharmaceuticals IncREGN
+23.72%$586.96$726.21
2025-08-26 -
2025-12-10
Buy

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biohaven LtdBHVN
3Hold$9.00-15.09%Downgrades
a month ago
Biogen IncBIIB
1Hold$157.00-11.57%Maintains
a month ago
Biomarin Pharmaceutical IncBMRN
5Buy$88.00+63.87%Maintains
a month ago
Intellia Therapeutics IncNTLA
2Hold$14.50+54.75%Downgrades
a month ago
Avidity Biosciences IncRNA
1Hold$72.00+0.91%Downgrades
a month ago
Regeneron Pharmaceuticals IncREGN
3Buy$781.00+7.54%Maintains
3 months ago
Sarepta Therapeutics IncSRPT
1Hold$13.00-41.44%Initiates Coverage On
4 months ago
Alnylam Pharmaceuticals IncALNY
2Buy$310.00-23.35%Maintains
a year ago
Arrowhead Pharmaceuticals IncARWR
2Hold$24.00N/AMaintains
a year ago
Vertex Pharmaceuticals IncVRTX
4Buy$390.00N/AMaintains
2 years ago
Beam Therapeutics IncBEAM
1Hold$37.00N/AInitiates Coverage On
3 years ago
Allogene Therapeutics IncALLO
1Hold$6.00N/AInitiates Coverage On
3 years ago
Crispr Therapeutics AgCRSP
1Hold$44.00N/AInitiates Coverage On
3 years ago
Ionis Pharmaceuticals IncIONS
1Sell$31.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.